169 related articles for article (PubMed ID: 35097133)
41. IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils.
Tosello Boari J; Amezcua Vesely MC; Bermejo DA; Ramello MC; Montes CL; Cejas H; Gruppi A; Acosta Rodríguez EV
PLoS Pathog; 2012; 8(4):e1002658. PubMed ID: 22577359
[TBL] [Abstract][Full Text] [Related]
42. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
43. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
[TBL] [Abstract][Full Text] [Related]
44. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
[TBL] [Abstract][Full Text] [Related]
45. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase.
Guedes PM; Veloso VM; Afonso LC; Caliari MV; Carneiro CM; Diniz LF; Marques-da-Silva EA; Caldas IS; Do Valle Matta MA; Souza SM; Lana M; Chiari E; Galvão LM; Bahia MT
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):43-52. PubMed ID: 19211152
[TBL] [Abstract][Full Text] [Related]
46. Circulating Cytokine and Chemokine Profiles of Trypanosoma cruzi-Infected Women During Pregnancy and Its Association With Congenital Transmission.
Volta BJ; Bustos PL; González C; Natale MA; Perrone AE; Milduberger N; Laucella SA; Bua J
J Infect Dis; 2021 Sep; 224(6):1086-1095. PubMed ID: 33528501
[TBL] [Abstract][Full Text] [Related]
47. The β-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi.
Horta AL; Figueiredo VP; Leite ALJ; Costa GP; Menezes APJ; Ramos CO; Pedrosa TCF; Bezerra FS; Vieira PMA; Talvani A
Mem Inst Oswaldo Cruz; 2018 Oct; 113(11):e180271. PubMed ID: 30365644
[TBL] [Abstract][Full Text] [Related]
48. Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.
Bonney KM; Taylor JM; Thorp EB; Epting CL; Engman DM
Parasitol Res; 2015 Mar; 114(3):1167-78. PubMed ID: 25576191
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi.
Gao W; Pereira MA
Int J Parasitol; 2002 Feb; 32(2):167-70. PubMed ID: 11812493
[TBL] [Abstract][Full Text] [Related]
50. Ebi3 Prevents
Medina TS; Oliveira GG; Silva MC; David BA; Silva GK; Fonseca DM; Sesti-Costa R; Frade AF; Baron MA; Ianni B; Pereira AC; Chevillard C; Cunha-Neto E; Marin-Neto JA; Silva JS
Front Immunol; 2017; 8():1213. PubMed ID: 29033934
[TBL] [Abstract][Full Text] [Related]
51. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18.
Müller U; Köhler G; Mossmann H; Schaub GA; Alber G; Di Santo JP; Brombacher F; Hölscher C
J Immunol; 2001 Sep; 167(6):3346-53. PubMed ID: 11544324
[TBL] [Abstract][Full Text] [Related]
52. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
[TBL] [Abstract][Full Text] [Related]
53. [Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection].
Moreno EA; Rivera IM; Moreno SC; Alarcón ME; Lugo-Yarbuh A
Invest Clin; 2003 Sep; 44(3):241-54. PubMed ID: 14552062
[TBL] [Abstract][Full Text] [Related]
54. Virulence of
Queiroga TBD; Pereira NS; da Silva DD; Andrade CM; de Araújo Júnior RF; Brito CRDN; Galvão LMDC; da Câmara ACJ; Nascimento MSL; Guedes PMM
Front Cell Infect Microbiol; 2021; 11():696719. PubMed ID: 34336720
[TBL] [Abstract][Full Text] [Related]
55. Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease.
de Paula Costa G; Silva RR; Pedrosa MC; Pinho V; de Lima WG; Teixeira MM; Bahia MT; Talvani A
Parasite Immunol; 2010 Mar; 32(3):202-8. PubMed ID: 20398183
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.
Bang BR; Kwon HS; Kim SH; Yoon SY; Choi JD; Hong GH; Park S; Kim TB; Moon HB; Cho YS
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1021-30. PubMed ID: 24328857
[TBL] [Abstract][Full Text] [Related]
57. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi.
Hunter CA; Ellis-Neyes LA; Slifer T; Kanaly S; Grünig G; Fort M; Rennick D; Araujo FG
J Immunol; 1997 Apr; 158(7):3311-6. PubMed ID: 9120288
[TBL] [Abstract][Full Text] [Related]
58. Host Genetics Background Influence in the Intragastric
Domingues CS; Cardoso FO; Hardoim DJ; Pelajo-Machado M; Bertho AL; Calabrese KDS
Front Immunol; 2020; 11():566476. PubMed ID: 33329529
[TBL] [Abstract][Full Text] [Related]
59. Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease.
Vitelli-Avelar DM; Sathler-Avelar R; Mattoso-Barbosa AM; Gouin N; Perdigão-de-Oliveira M; Valério-Dos-Reis L; Costa RP; Elói-Santos SM; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; Dick EJ; Hubbard GB; VandeBerg JF; VandeBerg JL
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005233. PubMed ID: 28225764
[TBL] [Abstract][Full Text] [Related]
60. Disease Tolerance and Pathogen Resistance Genes May Underlie
Chevillard C; Nunes JPS; Frade AF; Almeida RR; Pandey RP; Nascimento MS; Kalil J; Cunha-Neto E
Front Immunol; 2018; 9():2791. PubMed ID: 30559742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
